411.2 HLA molecular mismatch as a predictor of rejection and donor-specific antibodies in pediatric liver transplantation
Mr. Guido Trezeguet Renatti, Argentina
411.3 Oral application of low-dosage prednisone is efficient in reversing allograft fibrosis during long-term follow-up
Dr. Yuan Liu, People's Republic of China
411.4 Flow measurement in pediatric liver transplantation: a pilot study
Dr. Ane M. Andres, Spain
411.5 Safety and efficacy of PTA and stent placement for portal vein stenosis after pediatric liver transplantation; findings from the PORTAL registry
Lydia Sieben, Netherlands
411.6 Age matching improves graft survival in adolescent liver transplantation
Amanda R Jensen, United States
411.7 Liver Transplantation for Acute Liver Failure: Auxiliary or Non-Auxiliary Transplantation?
Prof. Li-Ying Sun, People's Republic of China
411.8 2D-Shear Wave Elastography of Pediatric Liver Transplants
Dr. Benas Prusinskas, Lithuania
411.9 Long-term outcomes of percutaneous stent angioplasty for vein stenosis after pediatric liver transplantation
Ms. Min Kyoung Kim, Korea
411.10 (411.1 in Journal) Poor one-year outcomes of hepatic artery thrombosis after pediatric liver transplantation: Results from an international, multicenter, real-world registry